Evitria AG, a global antibody expression service provider, announces that it has crossed the 100-citation threshold on Google Scholars. Google Scholar is a freely accessible web search engine that indexes the full text or metadata of scholarly literature across an array of publishing formats and disciplines. Researchers around the globe use evitria's services to advance their research and publish their ground-breaking findings in renowned scientific journals.

Among many other highly cited publications, one recent scientific article in Nature Medicine by Ghorashian et al., University College London, describes how evitria's production capabilities of an Anti-CAT CAR Idiotype antibody contributed to a clinical study to assess CAR+ T cells in pediatric patients with acute lymphoblastic leukemia.